Our research focuses on developing protein modulators in order to study structure-function aspects of cellular protein networks and to develop new drugs targeting protein-protein interactions (PPIs) with both small molecules and optimized protein variants.
Drug discovery is a multidisciplinary science by nature and requires the understanding and application of biology, chemistry, pharmacology and biophysical tools.
Current Research Programs
-
Small-molecule modulators of disease-associated protein–protein interactions
-
Rationally engineered anti-inflammatory peptides for autoimmune disorders
-
Novel immunosuppressive strategies targeting calcineurin–NFAT signaling
-
Engineered protein therapeutics as next-generation non-antibody biologics
-
Engineering of bispecific proteins for dual targeting of cellular receptors
-
Natural protein bio-preservatives for antifungal food protection and shelf-life extension